Pharmacy in Practice (PiP) is a recognised and respected title for decision-makers within acute trusts and primary care organisations.

 Peer-reviewed past issues

 Sole-sponsored supplements

Pharmacy in Practice – Special edition

Now published – three new articles

These new PiP supplements cover the current issues and debates on generic prescribing and highlight the impact of generic losartan in the hypertensive market.

Generic prescribing – what are the benefits and what are the risks?

With further debate on generic substitution, this article reviews the literature to consolidate the pros and cons of generic prescribing…

Perceptions of generic medicines and the cost-benefits of
generic switches

Perceptions on generic prescribing are varied – from healthcare professionals to patients – here we debate the real issues associated with generics and the cost considerations required…

The angiotensin receptor blocker (ARB) hypertensive market –
timeline to generics

One of the next markets to be hit with generics is the ARB market; this article reviews the implications of generic losartan and provides some considerations for local decision-makers…

If you would like to sponsor a PiP supplement please contact pip@medicomgroup.com.